This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

PDI, Inc. To Hold Fourth Quarter And Full Year 2009 Financial Results Conference Call On Thursday, March 4, 2010

PARSIPPANY, N.J., Feb. 25 /PRNewswire-FirstCall/ -- PDI, Inc. (Nasdaq: PDII), a leading provider of sales and marketing support to U.S. health care companies, today announced that it will release its fourth quarter and full year 2009 financial results on Thursday, March 4, 2010 after the market close.

PDI will host an investment community conference call beginning at 4:30 p.m. Eastern time on March 4, 2010 to discuss the results. To participate in the live conference call by telephone, please dial (866) 644-4654 from the U.S. and Canada, or for international callers, please dial (706) 643-1203. The conference ID number is 54709533.

Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of PDI's web site at www.pdi-inc.com. A replay will be available on the web site. A telephone replay will be available from 7:30 p.m. Eastern time on March 4, 2010 through 11:59 p.m. Eastern time on March 6, 2010 by dialing (800) 642-1687 (U.S. and Canada) or (706) 645-9291 and entering conference ID number 54709533.

About PDI

PDI provides commercialization services for established and emerging biopharmaceutical companies. The Company is dedicated to maximizing the return on investment for its clients by providing strategic flexibility, sales and marketing expertise. For more information, please visit the Company's website at www.pdi-inc.com.

SOURCE PDI, Inc.

Copyright 2009 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
PDII $1.00 -3.80%
AAPL $125.80 -2.25%
FB $77.56 -1.59%
GOOG $531.81 -1.70%
TSLA $232.95 1.06%

Markets

DOW 17,928.20 -142.20 -0.79%
S&P 500 2,089.46 -25.03 -1.18%
NASDAQ 4,939.3270 -77.6020 -1.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs